SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A decent increase of about 42.43% in the sales to Rs. 3915.85 millions was observed for the quarter ended December 2021. The sales figure stood at Rs. 2749.33 millions during the year-ago period.A good growth in profit of 40.31% reported to Rs. 1369.94  millions over Rs. 976.35 millions of corresponding previous quarter.Operating profit surged to 1953.02 millions from the corresponding previous quarter of 1421.77 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 3915.85 2749.33 42.43 9563.74 7505.53 27.42 10097.19 8337.90 21.10
Other Income 92.74 48.43 91.49 533.92 109.39 388.09 142.37 181.17 -21.42
PBIDT 1953.02 1421.77 37.37 4758.11 3577.67 32.99 4547.59 3997.59 13.76
Interest 7.42 19.10 -61.15 40.43 72.73 -44.41 91.44 186.62 -51.00
PBDT 1945.60 1402.67 38.71 4717.68 3504.94 34.60 4456.15 3810.97 16.93
Depreciation 105.06 87.58 19.96 286.76 233.21 22.96 316.36 235.07 34.58
PBT 1840.54 1315.09 39.96 4430.92 3271.73 35.43 4139.79 3575.90 15.77
TAX 470.60 338.74 38.93 1094.59 829.78 31.91 1053.32 875.10 20.37
Deferred Tax 8.53 -5.68 -250.18 33.09 -3.90 -948.46 36.17 -12.99 -378.44
PAT 1369.94 976.35 40.31 3336.33 2441.95 36.63 3086.47 2700.80 14.28
Equity 254.57 254.57 0.00 254.57 254.57 0.00 254.57 127.28 100.01
PBIDTM(%) 49.87 51.71 -3.56 49.75 47.67 4.37 45.04 47.94 -6.06

Cohance Lifesciences Share Price

391.60 28.35 (7.80%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×